Healthcare and market reform initiatives are compelling healthcare payers to evolve from transaction management business models to information management business models. As payers transform themselves to provide value, rationalize cost and innovate for differentiation, they are challenged by lack of realistic information, increased patient influence, and policy changes that point to more government involvement in the future.

Information is critical for payers to make health care decisions for their members. To meet Payers’ requirements, it is the current need of the Pharmaceutical companies to build the capability to conduct a wider range of conclusive studies covering comparative effectiveness across products and standards of care, epidemiological meta-analyses, patient-reported outcome analyses, and retrospective database analyses.

Hexaware’s Advanced Payer Analytics is a platform that delivers reports from a Payer Analytics perspective addressing the Payer objectives. The Advanced Payer Analytics is built over the following analysis models

• Comparative Effectiveness Research(CER)
• Cost Effective Analysis(CEA)
• Evidence Based Medicine (EBM)
• Pay For Performance

Key Tangible Benefits

Hexaware’s Advanced Payer Analytical reports provides the payers with information that can be used to

• Analyze Pharmaceutical products’ efficacy, safety, and value
• Improve the quality of health care services and reduce health care costs
• Help to make informed decisions leading to quality health care at low cost
• Ensure that their networks use only medically proven and cost-effective treatments
• Used for health economic analysis, enabling payers to make better decisions regarding reimbursement and coverage.
• Manage risk and improve the efficiency and effectiveness of their operations